Logo image of JEN.BR

JENSEN-GROUP NV (JEN.BR) Stock Fundamental Analysis

EBR:JEN - Euronext Brussels - BE0003858751 - Common Stock - Currency: EUR

57.8  +0.8 (+1.4%)

Fundamental Rating

6

JEN gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 107 industry peers in the Machinery industry. JEN has an excellent profitability rating, but there are some minor concerns on its financial health. JEN has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

JEN had positive earnings in the past year.
In the past year JEN had a positive cash flow from operations.
In the past 5 years JEN has always been profitable.
JEN had a positive operating cash flow in 4 of the past 5 years.
JEN.BR Yearly Net Income VS EBIT VS OCF VS FCFJEN.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

JEN has a Return On Assets of 7.97%. This is amongst the best in the industry. JEN outperforms 86.92% of its industry peers.
JEN's Return On Equity of 14.57% is amongst the best of the industry. JEN outperforms 81.31% of its industry peers.
JEN has a Return On Invested Capital of 11.74%. This is amongst the best in the industry. JEN outperforms 85.98% of its industry peers.
JEN had an Average Return On Invested Capital over the past 3 years of 9.39%. This is in line with the industry average of 8.98%.
The last Return On Invested Capital (11.74%) for JEN is above the 3 year average (9.39%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.97%
ROE 14.57%
ROIC 11.74%
ROA(3y)6.55%
ROA(5y)5.36%
ROE(3y)12.05%
ROE(5y)10.23%
ROIC(3y)9.39%
ROIC(5y)8.21%
JEN.BR Yearly ROA, ROE, ROICJEN.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

JEN's Profit Margin of 9.08% is amongst the best of the industry. JEN outperforms 85.05% of its industry peers.
JEN's Profit Margin has improved in the last couple of years.
With a decent Operating Margin value of 11.20%, JEN is doing good in the industry, outperforming 77.57% of the companies in the same industry.
JEN's Operating Margin has improved in the last couple of years.
The Gross Margin of JEN (13.64%) is worse than 89.72% of its industry peers.
JEN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 11.2%
PM (TTM) 9.08%
GM 13.64%
OM growth 3Y8.87%
OM growth 5Y10.05%
PM growth 3Y17.42%
PM growth 5Y13.94%
GM growth 3Y8.28%
GM growth 5Y10.4%
JEN.BR Yearly Profit, Operating, Gross MarginsJEN.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), JEN is creating some value.
The number of shares outstanding for JEN has been reduced compared to 1 year ago.
The number of shares outstanding for JEN has been increased compared to 5 years ago.
The debt/assets ratio for JEN is higher compared to a year ago.
JEN.BR Yearly Shares OutstandingJEN.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
JEN.BR Yearly Total Debt VS Total AssetsJEN.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

JEN has an Altman-Z score of 3.43. This indicates that JEN is financially healthy and has little risk of bankruptcy at the moment.
JEN's Altman-Z score of 3.43 is fine compared to the rest of the industry. JEN outperforms 79.44% of its industry peers.
The Debt to FCF ratio of JEN is 3.68, which is a good value as it means it would take JEN, 3.68 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 3.68, JEN is doing good in the industry, outperforming 69.16% of the companies in the same industry.
JEN has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of JEN (0.08) is better than 85.98% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 3.68
Altman-Z 3.43
ROIC/WACC1.63
WACC7.22%
JEN.BR Yearly LT Debt VS Equity VS FCFJEN.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

A Current Ratio of 1.73 indicates that JEN should not have too much problems paying its short term obligations.
JEN has a Current ratio of 1.73. This is comparable to the rest of the industry: JEN outperforms 59.81% of its industry peers.
A Quick Ratio of 1.35 indicates that JEN should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.35, JEN is in the better half of the industry, outperforming 75.70% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.73
Quick Ratio 1.35
JEN.BR Yearly Current Assets VS Current LiabilitesJEN.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 26.20% over the past year.
JEN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 16.40% yearly.
The Revenue has grown by 13.26% in the past year. This is quite good.
Measured over the past years, JEN shows a small growth in Revenue. The Revenue has been growing by 6.41% on average per year.
EPS 1Y (TTM)26.2%
EPS 3Y32.2%
EPS 5Y16.4%
EPS Q2Q%37.94%
Revenue 1Y (TTM)13.26%
Revenue growth 3Y20.39%
Revenue growth 5Y6.41%
Sales Q2Q%16.76%

3.2 Future

The Earnings Per Share is expected to grow by 5.01% on average over the next years.
The Revenue is expected to grow by 3.68% on average over the next years.
EPS Next Y6.19%
EPS Next 2Y5.39%
EPS Next 3Y4.65%
EPS Next 5Y5.01%
Revenue Next Year12.93%
Revenue Next 2Y8.38%
Revenue Next 3Y6.45%
Revenue Next 5Y3.68%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
JEN.BR Yearly Revenue VS EstimatesJEN.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M 400M 500M
JEN.BR Yearly EPS VS EstimatesJEN.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4 5

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 13.35, which indicates a correct valuation of JEN.
76.64% of the companies in the same industry are more expensive than JEN, based on the Price/Earnings ratio.
JEN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.69.
With a Price/Forward Earnings ratio of 11.92, the valuation of JEN can be described as very reasonable.
Based on the Price/Forward Earnings ratio, JEN is valued a bit cheaper than 64.49% of the companies in the same industry.
JEN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 37.36.
Industry RankSector Rank
PE 13.35
Fwd PE 11.92
JEN.BR Price Earnings VS Forward Price EarningsJEN.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as JEN.
The rest of the industry has a similar Price/Free Cash Flow ratio as JEN.
Industry RankSector Rank
P/FCF 29.51
EV/EBITDA 9.26
JEN.BR Per share dataJEN.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates JEN does not grow enough to justify the current Price/Earnings ratio.
JEN has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.15
PEG (5Y)0.81
EPS Next 2Y5.39%
EPS Next 3Y4.65%

3

5. Dividend

5.1 Amount

JEN has a Yearly Dividend Yield of 1.22%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.84, JEN has a dividend in line with its industry peers.
With a Dividend Yield of 1.22, JEN pays less dividend than the S&P500 average, which is at 2.34.
Industry RankSector Rank
Dividend Yield 1.22%

5.2 History

The dividend of JEN decreases each year by -5.10%.
Dividend Growth(5Y)-5.1%
Div Incr Years2
Div Non Decr Years4
JEN.BR Yearly Dividends per shareJEN.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

17.86% of the earnings are spent on dividend by JEN. This is a low number and sustainable payout ratio.
DP17.86%
EPS Next 2Y5.39%
EPS Next 3Y4.65%
JEN.BR Yearly Income VS Free CF VS DividendJEN.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M
JEN.BR Dividend Payout.JEN.BR Dividend Payout, showing the Payout Ratio.JEN.BR Dividend Payout.PayoutRetained Earnings

JENSEN-GROUP NV

EBR:JEN (7/24/2025, 5:29:53 PM)

57.8

+0.8 (+1.4%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-19 2025-05-19
Earnings (Next)08-07 2025-08-07
Inst Owners9.15%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap556.61M
Analysts80
Price Target54.57 (-5.59%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.22%
Yearly Dividend0.77
Dividend Growth(5Y)-5.1%
DP17.86%
Div Incr Years2
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)122.92%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.47%
Valuation
Industry RankSector Rank
PE 13.35
Fwd PE 11.92
P/S 1.23
P/FCF 29.51
P/OCF 18.18
P/B 1.97
P/tB 2.42
EV/EBITDA 9.26
EPS(TTM)4.33
EY7.49%
EPS(NY)4.85
Fwd EY8.39%
FCF(TTM)1.96
FCFY3.39%
OCF(TTM)3.18
OCFY5.5%
SpS47.06
BVpS29.35
TBVpS23.91
PEG (NY)2.15
PEG (5Y)0.81
Profitability
Industry RankSector Rank
ROA 7.97%
ROE 14.57%
ROCE 15.62%
ROIC 11.74%
ROICexc 14.09%
ROICexgc 17.48%
OM 11.2%
PM (TTM) 9.08%
GM 13.64%
FCFM 4.16%
ROA(3y)6.55%
ROA(5y)5.36%
ROE(3y)12.05%
ROE(5y)10.23%
ROIC(3y)9.39%
ROIC(5y)8.21%
ROICexc(3y)11.13%
ROICexc(5y)10.46%
ROICexgc(3y)12.99%
ROICexgc(5y)12.14%
ROCE(3y)13.16%
ROCE(5y)11.32%
ROICexcg growth 3Y5.22%
ROICexcg growth 5Y2.88%
ROICexc growth 3Y5.28%
ROICexc growth 5Y0.03%
OM growth 3Y8.87%
OM growth 5Y10.05%
PM growth 3Y17.42%
PM growth 5Y13.94%
GM growth 3Y8.28%
GM growth 5Y10.4%
F-Score6
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 3.68
Debt/EBITDA 0.37
Cap/Depr 132.29%
Cap/Sales 2.59%
Interest Coverage 28.09
Cash Conversion 51.35%
Profit Quality 45.81%
Current Ratio 1.73
Quick Ratio 1.35
Altman-Z 3.43
F-Score6
WACC7.22%
ROIC/WACC1.63
Cap/Depr(3y)117.95%
Cap/Depr(5y)108.4%
Cap/Sales(3y)2.08%
Cap/Sales(5y)2.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.2%
EPS 3Y32.2%
EPS 5Y16.4%
EPS Q2Q%37.94%
EPS Next Y6.19%
EPS Next 2Y5.39%
EPS Next 3Y4.65%
EPS Next 5Y5.01%
Revenue 1Y (TTM)13.26%
Revenue growth 3Y20.39%
Revenue growth 5Y6.41%
Sales Q2Q%16.76%
Revenue Next Year12.93%
Revenue Next 2Y8.38%
Revenue Next 3Y6.45%
Revenue Next 5Y3.68%
EBIT growth 1Y24.53%
EBIT growth 3Y31.06%
EBIT growth 5Y17.1%
EBIT Next Year51.02%
EBIT Next 3Y17.26%
EBIT Next 5Y12.63%
FCF growth 1Y39.35%
FCF growth 3Y-6.22%
FCF growth 5Y1.6%
OCF growth 1Y41.62%
OCF growth 3Y-2.15%
OCF growth 5Y3.17%